IRIS
CACCIOLA, Emma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.104
AS - Asia 6.157
EU - Europa 6.061
SA - Sud America 1.157
AF - Africa 252
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
Totale 26.751
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.537
SG - Singapore 3.634
RU - Federazione Russa 1.833
CN - Cina 1.707
IE - Irlanda 1.325
UA - Ucraina 1.255
BR - Brasile 1.009
IT - Italia 749
CA - Canada 488
VN - Vietnam 268
DE - Germania 186
GB - Regno Unito 154
SE - Svezia 135
IN - India 115
KR - Corea 109
CI - Costa d'Avorio 105
NL - Olanda 61
PL - Polonia 61
FR - Francia 59
CH - Svizzera 55
AR - Argentina 54
MX - Messico 50
BD - Bangladesh 44
UZ - Uzbekistan 42
FI - Finlandia 36
JP - Giappone 36
ZA - Sudafrica 33
EC - Ecuador 30
TR - Turchia 29
ES - Italia 28
KE - Kenya 23
AT - Austria 18
ID - Indonesia 18
GR - Grecia 17
HK - Hong Kong 17
IQ - Iraq 17
CZ - Repubblica Ceca 16
EG - Egitto 16
LB - Libano 16
NG - Nigeria 16
CO - Colombia 15
BJ - Benin 14
SN - Senegal 14
VE - Venezuela 14
BE - Belgio 13
MA - Marocco 13
RO - Romania 13
SA - Arabia Saudita 13
PE - Perù 12
TW - Taiwan 12
BG - Bulgaria 11
PK - Pakistan 11
PY - Paraguay 11
EU - Europa 8
IR - Iran 8
LT - Lituania 8
AU - Australia 7
JO - Giordania 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
BY - Bielorussia 5
DZ - Algeria 5
JM - Giamaica 5
KW - Kuwait 5
KZ - Kazakistan 5
LY - Libia 5
MY - Malesia 5
PT - Portogallo 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
NP - Nepal 4
CL - Cile 3
CR - Costa Rica 3
KG - Kirghizistan 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GF - Guiana Francese 1
GY - Guiana 1
Totale 26.736
Salva come PNG Salva come JPEG
Città #
Dallas 2.531
Singapore 1.978
Dublin 1.321
Jacksonville 1.218
Santa Clara 1.171
Chandler 954
Ashburn 907
Moscow 683
San Jose 648
Boardman 526
Nanjing 422
Andover 367
Cambridge 360
Toronto 355
Lawrence 353
Hefei 247
San Mateo 229
Des Moines 200
Chicago 194
Los Angeles 177
Wilmington 144
Beijing 140
Catania 139
Nanchang 123
Seoul 108
Abidjan 105
Hebei 98
Shenyang 95
Ho Chi Minh City 91
São Paulo 90
Saint Petersburg 84
Grafing 77
Ottawa 76
Jiaxing 75
Civitanova Marche 73
New York 71
Buffalo 68
Changsha 68
Tianjin 66
Warsaw 48
Hanoi 42
Council Bluffs 41
Rio de Janeiro 38
Bari 34
Montreal 33
Tokyo 32
Dong Ket 30
Phoenix 30
Seattle 30
Brooklyn 29
Bremen 28
Boston 27
Denver 26
Milan 26
Orem 26
Washington 26
Kunming 25
Norwalk 25
Poplar 25
Redondo Beach 25
Johannesburg 24
Munich 24
San Francisco 24
Palermo 23
Amsterdam 22
Den Haag 22
Houston 22
Atlanta 21
Pune 21
Belo Horizonte 20
Quito 20
Stockholm 20
Hangzhou 19
Liberty Lake 19
Ann Arbor 18
Curitiba 18
Tashkent 18
Brasília 17
Chennai 17
Abuja 16
Helsinki 16
Manchester 16
Mexico City 16
Mumbai 16
Hong Kong 15
London 15
Augusta 14
Cotonou 14
Dakar 14
Jinan 14
Ningbo 14
The Dalles 14
Brussels 13
Columbus 13
Kochi 13
Porto Alegre 13
Rome 13
Secaucus 13
Ankara 11
Charlotte 11
Totale 17.961
Salva come PNG Salva come JPEG
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 459
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 188
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 183
B-linfociti CALLA (CD10) positivi nella leucemia linfatica cronica. 176
Contributo delle piastrine reticolate alla generazione del fattore tessutale e del fattore di crescita trasformante-beta nella mielofibrosi primaria. Reticulated platelets contribution to tissue factor and transforming growth factor-beta generation in primary myelofibrosis. 170
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 164
Thrombotic risk stratification in patients with prefibrotic myelofibrosis 154
Activation of coaugulation and fibrinolysis in laparoscopic surgery 151
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 145
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 141
A rare case of myeloid sarcoma presenting as anal fissure. 137
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 132
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 132
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 130
Abnormal Erytropoietin serum levels in acute leukemia could have a role in the pathophysiology of disease. 129
Activation coagulation and fibrinolysis in laparoscopic surgery 129
Activation of coagulation anf fibrinolysis in laparoscopic surgery 129
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 128
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 128
Alterations in ornithine decarboxylase and transglutaminase activities in lymphocytes from untrated patients with chronic lymphocytic leukemia. 125
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 123
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 123
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 122
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 121
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 118
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 116
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 116
Is it Still Reasonable to Raise Doubts on Laparoscopic Splenectomy? 116
Phase II randomized clinical trial comparing ropeginterferon versus phlebotomy in low-risk patients with polycythemia vera. Results of the pre-planned interim analysis. 113
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 112
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 112
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 112
Idiopathic intramural hematoma of the right colon. A case report and review of the literature. 112
Acute lymphoblastic leukemia in elderly. 110
How to prevent intraoperative risks and complications in laparoscopic splenectomy 109
Hemocoagulative Modifications after Laparoscopic Surgery at Different Pneumoperitoneum Pressure Settings. 107
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 107
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 107
Laparoscopic splenectomy: a single center experience 106
. Trombospondin plasma levels in beta tha- lassemia:sickle cell disease 106
Alteration of endothelium-coagulative system during COPD exacerbations 106
"In vitro" hyperresponsivity of diabetic platelets to "saturated" platelet-activating factor (PAF). 104
Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms 104
Chronic idiopatic trombocytopenic purpura: is there any factor to predict the response to splenectomy? 100
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 99
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 99
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 97
Acquired antithrombin III deficency in sickle cell disease/beta plus thalas- semia. 97
Cessazione del fumo di sigaretta e riduzione dei livelli plasmatici di fattore di von Willebrand (vWF) 96
Splanchnic vein thrombosis in JAK2V617F-positive patients with primary myelofibrosis and lower-risk IPSS. 95
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 95
Long-term results after splenectomy in adult idiopathic thrombocitopenic purpura: comparison between open and laparoscopic procedures 93
Low dose of ARA-C in chronic myeloid leukemia in blastic transformation 92
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 92
In vitro sensitivity of B-CLL cells to Fludarabine and Interferons 92
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 92
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 92
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 91
Modification of coaugulation and fibrinolysic parameters in laparoscopic cholecystectomy 91
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 90
The Antiphospholipid Syndrome 90
The use of surgical drains in laparoscopic splenectomies. Consideration on a large series of 117 consecutive cases 90
I disordini dell'emostasi nelle emopatie maligne. 89
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 89
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 89
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 88
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 87
Alpha interferon as a first line therapy for angioimmunoblastic lympho- adenopathy. Possible value of DR+ cells in monitoring therapeutical re- sponse. 87
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 87
Retroperitoneal paraduodenal unicentric Castleman disease: case report and review of the literature 86
Immunomodulating treatment in patients with aplastic anemia. 86
All-trans retinoic acid might also induce apoptosis in freshly isolated chro- nic myeloid leukemia cells 86
B- chronic lymphocytic lekemia cells forming rosettes with sheep erythrocytes 86
T-subset abnormalities in Thalassemia intermedia: Possible evidence for a Thymus functional deficiency. 86
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 85
Unusual onset of severe varicella in adult immunocompromised patients 84
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 84
Le anemie carenziali. 83
Factor-VIII-rela- ted antigen and vasculitis. 83
The antiphospholipid syndrome in pregnancy: a review article 83
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 83
Il mitoxantrone in polichemioterapia associato allo schema CVP nel trat- tamento dei linfomi non hodgkin. 83
Trattamento preoperatorio con interleuchina-2 nel carcinoma colorettale. 82
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 82
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 82
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 81
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 81
Cutaneous vasculitis in non Hodgkin's Lymphoma. 80
Low-dose cytarabine in myelodisplastic syndromes and acute leukemia: a comment 80
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 80
MECCANISMO DI ATTIVAZIONE PIASTRINICA NELLA TROMBOCITEMIA ESSENZIALE: RUOLO DEGLI ANTICORPI ANTI CELLULA ENDOTELIALE (AACE) 79
Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta Thalassemia: a pilot study. 79
Laparoscopic splenectomy reduces the need of platelet transfusion in patients operated on for idiopathic thrombocytopenic purpura 79
Thymostimulin in aplastic anaemia. 78
Interleukin-8 levels in patients with essential thrombocythemia. 78
Effects of anagrelide on platelet and fibrinolytic function in patients with essential thrombocythemia 78
Surgical management of hereditary spherocytosis Current strategies 78
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis 77
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neolpasms 77
JAK2V6176F mutation status and thrombosis in essential thrombocytemia 77
Totale 10.737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.007
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021732 0 0 0 0 0 0 198 13 287 10 163 61
2021/20222.657 346 387 21 30 429 5 394 92 282 5 63 603
2022/20233.474 365 93 28 229 348 652 4 576 971 29 115 64
2023/20241.666 81 110 73 86 65 160 160 355 17 40 230 289
2024/20255.265 38 716 369 170 1.183 404 110 201 517 689 313 555
2025/20269.614 704 595 2.641 779 2.097 2.043 755 0 0 0 0 0
Totale 27.235